GATC Biotech

The deal will close in July and will expand Eurofins' capabilities in areas including DNA sequencing and genetic testing. 

GATC will provide next-generation sequencing services for Constance research projects, and they will work together to further develop sequencing methods.

GATC Biotech said it selected Bluebee's platform for its service because of its increased automation and flexibility.

The company, based in Constance, Germany, is launching three liquid biopsy assays as a research service this week that differ in target size and sensitivity.

GATC Biotech will sell and market Molecular Health's TreatmentMap next-generation sequencing-based tumor profiling platform around the world.

The firm's divisions will include Sequencing Solutions, Customized Solutions, and Diagnostics Solutions.

NEW YORK (GenomeWeb) – A new cancer personalized treatment service that SAP is offering to employees living with the disease provides an opportunity for the company to put its newly minted SAP Genomic Analyzer solution — a sequence alignment and analysis software that runs on the SAP Hana infrast

GATC Biotech has launched three different transcriptome sequencing services. InView Transcriptome Explore provides random primed cDNA libraries for Illumina sequencing using 50 bp single reads and guarantees at least 30 million single reads.

NEW YORK (GenomeWeb News) – MolecularHealth today announced an agreement under which GATC Biotech will provide its laboratory information management system in MolecularHealth's new clinical laboratory.

Agilent Technologies has optimized its SureSelect Target Enrichment solution for Life Technologies' Ion Proton.

Pages

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.